Health Law Diagnose: Health Care Transaction Review Laws and the New Normal

In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the evolving legislative and regulatory landscape impacting health care transactions, particularly for private equities and hedge funds. She is joined by Members Deb Daccord and Dan Cody, who share their insights on the likely impacts at the state level, including: An overview of state health care transaction review laws State approaches to material change transaction process Antitrust considerations in a transaction California’s changing laws: AB 1415 and SB 315 Key advice for contemplating health care transactions